Focused on development of novel therapeutic drugs for treatment of demyelinating, inflammatory and neurodegenerative diseases

Leveraging a unique combination of science and business acumen to bridge the gap between entrepreneurs and investors. For scientists, universities and entrepreneurs -· Advising on the commercialization and/or regulatory path for new technologies and products· Organizing and preparing materials for fundraising · Building a data room and facilitating effective communications with potential investors For angel investors, VCs and family offices -· Evaluating new technologies for merit and market acceptance · Performing a deep dive diligence review for investment consideration· Managing portfolio company operations and/or performance

Actively supporting early-stage technology-based ventures to validate key proof points, drive commercialization, attract partners and/or customers, access capital and support growth to scale.

BloomOK support due diligence activities and provides virtual health subject matter expertise to regional investors. By supporting existing sources of capital with BloomOK’s deep subject matter expertise, we aspire to unlock and expedite investment in the region’s virtual health start-ups.

Building biotech startup companies around life science technologies developed at Midwest universities.

• Managed the deal pipeline from search through closing across 3 venture funds • Led due diligence efforts to evaluate 40+ companies for potential investment • Closed $20M+ in funding from iMCI managed funds in venture rounds totaling $46M+• Actively participated in portfolio management for 10 companies with 2 board seats• Involved in strategy/business development, exit negotiations, and company restructuring • Evaluated bridge and/or follow on financing requirements for portfolio companies including assessment of progress on milestones specific to prior investment, proposed use of funds and goals for new capital

• Provided advisory services to 30+ clients across multiple tech-based industries• Identified management, capital, and regulatory requirements as needed and outlined mechanisms to achieve such requirements • Participated in deal negotiations, including review of deal documentation, due diligence, syndication and facilitation of closing for client companies receiving investment funds• Closed $15M+ in equity investments for 9 client companies

• Prepared market analyses and contact lists for university TTOs• Evaluated IP and assessed commercialization strategy for emerging technologies

• Involved in all aspects of business development and scientific research• Managed two technicians and directed daily tasks in the laboratory • Prepared briefing documents and facilitated Pre-IND meeting with the FDA• Wrote, assembled and managed successful NIH Phase I SBIR grant (awarded $218,000) and OCAST OARS grant (awarded $160,000)• Led investor relations

• Responsible for managing all aspects of preclinical development of EdX-17; • Worked closely with founders and investors to strategize and attain milestones; Prepared bi-monthly and annual reports for advisors and investors; Organized and led meetings with internal staff, advisors, collaborators, and investors

• Prepared SBIR Fast-Track grant application documents

Postdoctoral research with Courtney Griffin, PhDDevelopmental biology including embryonic dissections and histological techniques; Molecular biology including qPCR & ChIP; Analyzed/interpreted data; Wrote and submitted two manuscripts and one review article for peer-review and publication; Presented data at research conferences and departmental seminars.

Part-time internship

Part-time internship

Graduate research with Ann Nardulli, PhDMolecular biology including protein expression and purification; Troubleshot experiments; Analyzed/interpreted data; Mouse colony breeding and maintenance; Planned and implemented weekly lab meetings; Wrote and submitted three peer-reviewed papers and one book chapter; Collaborated with colleagues on several projects; Presented data at research conferences and departmental meetings.

Introduction to Human Physiology Lab (MCB 104)Systems & Integrative Physiology (MCB 402)Led laboratory sections of 15-20 students; Worked in a team of 6-8 course coordinators; Prepared, proctered and graded exams.

Research with Ann Nardulli, PhDMolecular biology; Troubleshot experiments and analyzed/interpreted data; Managed graduate students, undergraduate researchers and hourly workers; Organized purchasing and cataloging of supplies and reagents.

General Chemistry (CHEM 101 & CHEM 102)Led discussion sections (two 1-hr sessions per week) with 20-30 students; Planned lessons & designed quizzes to test knowledge.

Undergraduate research with Nian Shi, PhDProject: Increasing efficiency of lactic acid production in yeast. Proficiency in basic biochemistry and molecular biology techniques.

Undergraduate research with Paul D. Coleman, PhDProject: Gene expression in neurodegenerative disease.Basic understanding of molecular biology techniques.